Reuters logo
BRIEF-Astellas Pharma to acquire Ogeda SA
April 2, 2017 / 11:35 PM / in 8 months

BRIEF-Astellas Pharma to acquire Ogeda SA

April 3 (Reuters) - Astellas Pharma Inc:

* under agreement, Astellas has agreed to pay up to a total of eur 800 million

* Astellas will make an initial payment of eur 500 million in consideration of 100% of equity in Ogeda at closing of transaction

* Ogeda shareholders will be eligible to receive additional eur 300 million with attainment of certain milestones for fezolinetant

* Astellas is still reviewing impact of this transaction on its financial forecasts for fiscal year ending March 31, 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below